While IFN-g is generally thought to be the primary T cell-derived cytokine responsible for adaptive PD-L1 expression, a recent study [26] described several additional TME-resident cytokines, including IL-10 and IL-32g, which are capable of promoting PD-L1 expression on monocytes but not on tumor cells, becoming an important source of immunosuppression in the TME. The gene discussed is IFNG; the disease is neoplasm.